Institutions / SG Americas Securities, LLC / Activity
Activity — SG Americas Securities, LLC
6,121 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Add | Tilly'S, Inc. Common stock | $0 | +2 +<0.01% | 220,097 <0.01% of portfolio | low |
| Q2 2026 as of | Add | 06368M302 Common stock | $0 | +1 +0.04% | 2,450 <0.01% of portfolio | low |
| Q1 2026 as of | Add | FLGT Fulgent Genetics, Inc. Common Stock | $0 | +14 +0.08% | 18,356 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | GIC GLOBAL INDUSTRIAL Co Common Stock | $-0 | -10 -0.04% | 23,199 <0.01% of portfolio | low |
| Q1 2026 as of | Add | MFA Financial Inc Common stock | $0 | +38 +0.08% | 48,804 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | HERE Here Group Ltd ADR | $-0 | -214 -0.25% | 86,907 <0.01% of portfolio | low |
| Q1 2026 as of | Add | PLRX Pliant Therapeutics, Inc. Common Stock | $0 | +343 +2.80% | 12,604 <0.01% of portfolio | low |
| Q2 2026 as of | Add | DoubleDown Interactive Co., Ltd. Common stock | $0 | +40 +0.06% | 63,056 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | 87241L109 Common stock | $-0 | -3 -0.18% | 1,697 <0.01% of portfolio | low |
| Q1 2026 as of | Add | G6333L200 Common stock | $1 | +21K +161.81% | 33,464 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | HY Hyster-Yale, Inc. Common Stock | $-1 | -20 -0.51% | 3,905 <0.01% of portfolio | low |
| Q2 2026 as of | Add | ILPT Industrial Logistics Properties Trust REIT | $1 | +80 +0.71% | 11,412 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | REKR Rekor Systems, Inc. Common Stock | $-1 | -1K -0.15% | 679,855 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | AUTL Autolus Therapeutics plc ADR | $-1 | -571 -0.86% | 66,107 <0.01% of portfolio | low |
| Q1 2026 as of | Add | HERE Here Group Ltd ADR | $1 | +227 +0.26% | 87,121 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Dime Community Bancshares, Inc. /NY Common stock | $1 | +24 +0.19% | 12,717 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | Chegg, Inc Common stock | $-1 | -1K -9.59% | 10,516 <0.01% of portfolio | low |
| Q2 2026 as of | Add | American Integrity Insurance Group, Inc. Common stock | $1 | +48 +0.50% | 9,563 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | REKR Rekor Systems, Inc. Common Stock | $-1 | -1K -0.18% | 680,899 <0.01% of portfolio | low |
| Q2 2026 as of | Exit | G6333L200 Common stock | $-1 | -33K -100.00% | 0 | low |
| Q1 2026 as of | Exit | 74319X108 Common stock | $-1 | -14K -100.00% | 0 | low |
| Q2 2026 as of | New | G4808M118 Common stock | $1 | +24K | 24,000 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Rocket Pharmaceuticals, Inc. Common stock | $-1 | -314 -1.64% | 18,819 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Coherus Oncology, Inc. Common stock | $-1 | -770 -2.35% | 32,027 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Precigen, Inc. Common stock | $1 | +294 +0.75% | 39,613 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Myriad Genetics Inc Common stock | $-1 | -222 -0.43% | 51,643 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | Service Properties Trust Common stock | $-1 | -1K -2.53% | 40,703 <0.01% of portfolio | low |
| Q1 2026 as of | Add | NFE New Fortress Energy Inc. Common Stock | $2 | +3K +4.52% | 65,728 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | MLTX MoonLake Immunotherapeutics Common Stock | $-2 | -96 -1.03% | 9,254 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Everus Construction Group, Inc. Common stock | $2 | +16 +0.51% | 3,155 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Pursuit Attractions & Hospitality, Inc. Common stock | $-2 | -35 -0.75% | 4,645 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Sanofi Common stock | $2 | +46 +0.30% | 15,188 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | FMS Fresenius Medical Care Holdings, Inc. ADR | $-2 | -89 -0.86% | 10,221 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | TRIN Trinity Capital Inc. Common Stock | $-2 | -139 -0.97% | 14,215 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | Cullinan Therapeutics, Inc. Common stock | $-2 | -152 -0.97% | 15,479 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Blackline, Inc. Common stock | $2 | +59 +0.39% | 15,275 <0.01% of portfolio | low |
| Q2 2026 as of | Add | enCore Energy Corp. Common stock | $2 | +2K +2.10% | 83,470 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Core Laboratories Inc. /DE Common stock | $-2 | -199 -1.68% | 11,652 <0.01% of portfolio | low |
| Q2 2026 as of | Add | CRON Cronos Group Inc. Common Stock | $2 | +874 +7.84% | 12,021 <0.01% of portfolio | low |
| Q2 2026 as of | Trim | Biohaven Ltd. Common stock | $-2 | -163 -0.16% | 101,920 <0.01% of portfolio | low |
| Q1 2026 as of | Add | BHC Bausch Health Companies Inc. Common Stock | $3 | +476 +3.32% | 14,810 <0.01% of portfolio | low |
| Q2 2026 as of | Add | 29258Y103 Common stock | $3 | +328 +0.76% | 43,288 <0.01% of portfolio | low |
| Q2 2026 as of | Add | FMS Fresenius Medical Care Holdings, Inc. ADR | $3 | +120 +1.17% | 10,341 <0.01% of portfolio | low |
| Q1 2026 as of | Trim | Coherus Oncology, Inc. Common stock | $-3 | -2K -4.76% | 32,797 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Fulcrum Therapeutics, Inc. Common stock | $3 | +373 +3.17% | 12,139 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Gossamer Bio, Inc. Common stock | $3 | +18K +14.13% | 146,737 <0.01% of portfolio | low |
| Q1 2026 as of | Exit | G6796W115 Common stock | $-3 | -32K -100.00% | 0 | low |
| Q1 2026 as of | Add | Arrowhead Pharmaceuticals, Inc. Common stock | $3 | +51 +0.10% | 50,350 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Y81669106 Common stock | $4 | +444 +3.09% | 14,806 <0.01% of portfolio | low |
| Q1 2026 as of | Add | QSI Quantum-Si Inc Common Stock | $4 | +5K +15.70% | 33,677 <0.01% of portfolio | low |